Company intelligence / Profile preview

PathoLase

Ownership: Private
Development stage: Commercial

Overview

PathoLase developed and commercialized the PinPointe FootLaser, a laser device for the treatment of toenail fungus (onychomycosis). The company was active in 2009 and announced a corporate separation with PinPointe USA, Inc. at that time. There is no recent information confirming current activity.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

PinPointe FootLaser

Commercial

Indications: Onychomycosis

Beyond the preview

Go deeper on PathoLase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PathoLase.

Explore the full profile